Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CARDIOSKIN

K-Number: K173248 · 2018-08-11

Decision Date2018-08-11
Product CodeDXH
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CARDIOSKIN is the device name listed in this FDA 510(k) record. The listed applicant is Bioserenity Sas. It received FDA 510(k) clearance on 2018-08-11 under 510(k) number K173248. The device is classified under product code DXH. It was reviewed by the CV advisory panel. Product code DXH falls under the category of Hematology, which includes devices for blood cell counting, coagulation testing, and hemoglobin analysis. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CARDIOSKIN?

CARDIOSKIN is a medical device that received FDA 510(k) clearance on 2018-08-11. The listed applicant is Bioserenity Sas. The 510(k) number is K173248.

When did CARDIOSKIN receive FDA 510(k) clearance?

CARDIOSKIN received FDA 510(k) clearance on 2018-08-11, under 510(k) number K173248.

Who is the listed applicant for CARDIOSKIN?

The FDA 510(k) record lists Bioserenity Sas as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CARDIOSKIN?

The FDA product code for CARDIOSKIN is DXH. This falls under the Hematology category.

Other records listing Bioserenity Sas as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DXH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.